Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies

Biochemical Society Transactions

Volumn 40, Issue 4, 2012, Pages 661-666

  Brunden, Kurt R ^a   Ballatore, Carlo ^a,b   Lee, Virginia M Y ^b   Smith III, Amos B ^b   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Axon; Microtubule; Tauopathy; Therapeutic agent

Indexed keywords

EPOTHILONE D; PACLITAXEL; TAU PROTEIN;

BLOOD BRAIN BARRIER; CANCER PATIENT; COGNITIVE DEFECT; CONFERENCE PAPER; EXON; HUMAN; LOSS OF FUNCTION MUTATION; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; TAUOPATHY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; AXONS; EPOTHILONES; HUMANS; MICROTUBULES; TAUOPATHIES;

MUS;

EID: 84864395349     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120010     Document Type: Conference Paper

References (59)

1. Lee, V.M.Y., Goedert, M. and Trojanowski, J.Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159 (Pubitemid 32695256)
2. Ballatore, C., Lee, V.M.Y. and Trojanowski, J.Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663-672 (Pubitemid 47283144)
3. Cleveland, D.W., Hwo, S.Y. and Kirschner, M.W. (1977) Physical and chemical properties of purified tau factor and role of tau in microtubule assembly. J. Mol. Biol. 116, 227-247 (Pubitemid 8215105)
4. Cleveland, D.W., Connolly, J.A., Kalnins, V.I., Spiegelman, B.M. and Kirschner, M.W. (1977) Physical properties and cellular localization of tau, a microtubule-associated protein which induces assembly of purified tubulin. J. Cell Biol. 75, A283
5. Drechsel, D.N., Hyman, A.A., Cobb, M.H. and Kirschner, M.W. (1992) Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell 3, 1141-1154 (Pubitemid 23088964)
6. Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E.M. and Mandelkow, E. (1994) Domains of tau protein and interactions with microtubules. Biochemistry 33, 9511-9522 (Pubitemid 24272907)
7. Arriagada, P.V., Growdon, J.H., Hedleywhyte, E.T. and Hyman, B.T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639
8. Wilcock, G.K. and Esiri, M.M. (1982) Plaques, tangles and dementia: a quantitative study. J. Neurol. Sci. 56, 343-356 (Pubitemid 12002356)
9. Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J.H., Petersen, R.C., Parisi, J.E. and Hyman, B.T. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24 (Pubitemid 27057088)
10. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A. et al. (1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705
11. Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B.I., Geschwind, D.H., Bird, T.D., McKeel, D., Goate, A. et al. (1998) Mutation-specific functional impairments in distinct Tau isoforms of hereditary FTDP-17. Science 282, 1914-1917 (Pubitemid 28555275)
12. Edwards, T.L., Scott, W.K., Almonte, C., Burt, A., Powell, E.H., Beecham, G.W., Wang, L.Y., Zuchner, S., Konidari, I., Wang, G.F. et al. (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet. 74, 97-109
13. Simon-Sanchez, J., Schulte, C., Bras, J.M., Sharma, M., Gibbs, J.R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S.W., Hernandez, D.G. et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308-1312
14. Kotzbauer, P.T., Giasson, B.I., Kravitz, A.V., Golbe, L.I., Mark, M.H., Trojanowski, J.Q. and Lee, V.M.Y. (2004) Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation. Exp. Neurol. 187, 279-288 (Pubitemid 38610274)
15. Winton, M.J., Joyce, S., Zhukareva, V., Practico, D., Perl, D.P., Galasko, D., Craig, U., Trojanowski, J.Q. and Lee, V.M.Y. (2006) Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex. Acta Neuropathol. 111, 401-412
16. Brunden, K., Trojanowski, J.Q. and Lee, V.M.Y. (2008) Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J. Alzheimer's Dis. 14, 393-399
17. Lee, V.M.Y., Daughenbaugh, R. and Trojanowski, J.Q. (1994) Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol. Aging 15, S87-S89
18. Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. and Crowther, R.A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526
19. Goedert, M. and Jakes, R. (1990) Expression of separate isoforms of human tau protein: correlation with the tau-pattern in brain and effects on tubulin polymerization. EMBO J. 9, 4225-4230 (Pubitemid 120025977)
20. Andreadis, A., Brown, W.M. and Kosik, K.S. (1992) Structure and novel exons of the human tau gene. Biochemistry 31, 10626-10633
21. Panda, D., Samuel, J.C., Massie, M., Feinstein, S.C. and Wilson, L. (2003) Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease. Proc. Natl. Acad. Sci. U.S.A. 100, 9548-9553 (Pubitemid 37033965)
22. Hasegawa, M. (2006) Biochemistry and molecular biology of tauopathies. Neuropathology 26, 484-490
23. Ksiezak-Reding, H., Liu, W.K. and Yen, S.H. (1992) Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res. 597, 209-219 (Pubitemid 23003689)
24. Kopke, E., Tung, Y.C., Shaikh, S., Alonso, A.D., Iqbal, K. and GrundkeIqbal, I. (1993) Microtubule-associated protein tau: abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J. Biol. Chem. 268, 24374-24384 (Pubitemid 23335430)
25. Matsuo, E.S., Shin, R.W., Billingsley, M.L., Vandevoorde, A., Oconnor, M., Trojanowski, J.Q. and Lee, V.M.Y. (1994) Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament-tau. Neuron 13, 989-1002 (Pubitemid 24347311)
26. Alonso, A.D., GrundkeIqbal, I. and Iqbal, K. (1994) Abnormally phosphorylated tau from Alzheimer disease brain depolymerizes microtubules. Neurobiol. Aging 15, S37
27. Merrick, S.E., Trojanowski, J.Q. and Lee, V.M.Y. (1997) Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons (NT2N cells). J. Neurosci. 17, 5726-5737 (Pubitemid 27310488)
28. Wagner, U., Utton, M., Gallo, J.M. and Miller, C.C.J. (1996) Cellular phosphorylation of tau by GSK-3β influences tau binding to microtubules and microtubule organisation. J. Cell Sci. 109, 1537-1543 (Pubitemid 26190502)
29. Alonso, A.D., GrundkeIqbal, I. and Iqbal, K. (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2, 783-787
30. Necula, M. and Kuret, J. (2004) Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro. J. Biol. Chem. 279, 49694-49703 (Pubitemid 39577773)
31. Bramblett, G.T., Goedert, M., Jakes, R., Merrick, S.E., Trojanowski, J.Q. and Lee, V.M.Y. (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10, 1089-1099 (Pubitemid 23194399)
32. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. and Mandelkow, E.M. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156, 1051-1063 (Pubitemid 34839854)
33. Dixit, R., Ross, J.L., Goldman, Y.E. and Holzbaur, E.L.F. (2008) Differential regulation of dynein and kinesin motor proteins by tau. Science 319, 1086-1089 (Pubitemid 351300789)
34. Vershinin, M., Carter, B.C., Razafsky, D.S., King, S.J. and Gross, S.P. (2007) Multiple-motor based transport and its regulation by Tau. Proc. Natl. Acad. Sci. U.S.A. 104, 87-92 (Pubitemid 46067989)
35. Ittner, L.M., Ke, Y.D., Delerue, F., Bi, M.A., Gladbach, A., van Eersel, J., Wolfing, H., Chieng, B.C., Christie, M.J., Napier, I.A. et al. (2010) Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models. Cell 142, 387-397
36. Roberson, E.D., Scearce-Levie, K., Palop, J.J., Yan, F.R., Cheng, I.H., Wu, T., Gerstein, H., Yu, G.Q. and Mucke, L. (2007) Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754 (Pubitemid 46717684)
37. Cash, A.D., Aliev, G., Siedlak, S.L., Nunomura, A., Fujioka, H., Zhu, X.W., Raina, A.K., Vinters, H.V., Tabaton, M., Johnson, A.B. et al. (2003) Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am. J. Pathol. 162, 1623-1627 (Pubitemid 36512845)
38. Hempen, B. and Brion, J.P. (1996) Reduction of acetylated α-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55, 964-972 (Pubitemid 126449410)
39. Bramblett, G.T., Trojanowski, J.Q. and Lee, V.M.Y. (1992) Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau isoforms (A68 proteins). Lab. Invest. 66, 212-222
40. Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M.K., Trojanowski, J.Q. and Lee, V.M.Y. (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751-762
41. Zhang, B., Maiti, A., Shively, S., Lakhani, F., McDonald-Jones, G., Bruce, J., Lee, E.B., Xie, S.X., Joyce, S., Li, C. et al. (2005) Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl. Acad. Sci. U.S.A. 102, 227-231 (Pubitemid 40094457)
42. Brunden, K.R., Zhang, B., Carroll, J., Yao, Y., Potuzak, J.S., Hogan, A.-M.L., Iba, M., James, M.J., Xie, S.X., Ballatore, C. et al. (2010) Epothilone D improves microtubule density, axonal integrity and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 30, 13861-13866
43. Zhang, B., Carroll, J., Trojanowski, J.Q., Yao, Y., Iba, M., Potuzak, J.S., Hogan, A.L., Xie, S.X., Ballatore, C., Smith, II, A. et al. (2011) The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J. Neurosci. 32, 3601-3611
44. Cowan, C.M., Bossing, T., Page, A., Shepherd, D. and Mudher, A. (2010) Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol. 120, 593-604
45. Ballatore, C., Hyde, E., Deiches, R.F., Lee, V.M. Y., Trojanowski, J.Q., Huryn, D. and Smith, A.B. (2007) Paclitaxel C-10 carbamates: potential candidates for the treatment of neurodegenerative tauopathies. Bioorg. Med. Chem. Lett. 17, 3642-3646 (Pubitemid 46901107)
46. Rice, A., Liu, Y.B., Michaelis, M.L., Himes, R.H., Georg, G.I. and Audus, K.L. (2005) Chemical modification of paclitaxel (taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ. J. Med. Chem. 48, 832-838 (Pubitemid 40209105)
47. Ojima, I., Chen, J., Sun, L., Borella, C.P., Wang, T., Miller, M.L., Lin, S.N., Geng, X.D., Kuznetsova, L.R., Qu, C.X. et al. (2008) Design, synthesis, and biological evaluation of new-generation taxoids. J. Med. Chem. 51, 3203-3221 (Pubitemid 351821880)
48. Brunden, K.R., Yao, Y., Potuzak, J.S., Ferrar, N.I., Ballatore, C., James, M.J., Hogan, A.L., Trojanowski, J.Q., Smith, 3rd, A.B. and Lee, V.M.Y. (2011) The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies. Pharmacol. Res. 63, 341-351
49. Beer, T.M., Higano, C.S., Saleh, M., Dreicer, R., Hudes, G., Picus, J., Rarick, M., Fehrenbacher, L. and Hannah, A.L. (2007) Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel. Invest. New Drugs 25, 565-570
50. Cheng, K.L., Bradley, T. and Budman, D.R. (2008) Novel microtubule-targeting agents: the epothilones. Biol.: Targets Ther. 2, 789-811
51. Cortes, J. and Baselga, J. (2007) Targeting the microtubules in breast cancer beyond taxanes: the epothilones. Oncologist 12, 271-280 (Pubitemid 46556793)
52. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.M., Iwata, N., Saido, T.C., Maeda, J., Suhara, T., Trojanowski, J.Q. and Lee, V.M.Y. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337-351 (Pubitemid 46161268)
53. Matsuoka, Y., Gray, A.J., Hirata-Fukae, C., Minami, S.S., Waterhouse, E.G., Mattson, M.P., LaFerla, F.M., Gozes, I. and Aisen, P.S. (2007) Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage. J. Mol. Neurosci. 31, 165-170 (Pubitemid 46742300)
54. Matsuoka, Y., Jouroukhin, Y., Gray, A.J., Ma, L., Hirata-Fukae, C., Li, H.F., Feng, L., Lecanu, L., Walker, B.R., Planel, E. et al. (2008) A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 325, 146-153 (Pubitemid 351439178)
55. Kar, S., Fan, J., Smith, M.J., Goedert, M. and Amos, L.A. (2003) Repeat motifs of tau bind to the insides of microtubules in the absence of taxol. EMBO J. 22, 70-77 (Pubitemid 36091270)
56. Samsonov, A., Yu, J.Z., Rasenick, M. and Popov, S.V. (2004) Tau interaction with microtubules in vivo. J. Cell Sci. 117, 6129-6141 (Pubitemid 40123977)
57. Bollag, D.M., Mcqueney, P.A., Zhu, J., Hensens, O., Koupal, L., Liesch, J., Goetz, M., Lazarides, E. and Woods, C.M. (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res. 55, 2325-2333
58. Falzone, T.L., Gunawardena, S., McCleary, D., Reis, G.F. and Goldstein, L.S.B. (2010) Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies. Hum. Mol. Genet. 19, 4399-4408
59. Falzone, T.L., Stokin, G.B., Lillo, C., Rodrigues, E.M., Westerman, E.L., Williams, D.S. and Goldstein, L.S.B. (2009) Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects. J. Neurosci. 29, 5758-5767